top of page
NanoString Assays
In partnership with NanoString, we have developed numerous Laboratory Developed Tests (LTD) to improve in the molecular diagnosis and treatment selection for paediatric brain tumour patients. Our tests are clinically validated by a distinguished team of clinicians and scientists, and provide an innovative, efficient, and cost-effective solution to molceular diagnostics.
Clinically Offered:
-
Sarcoma fusion panel
-
Ependymoma fusion panel
-
ATRT subtyping panel
In Development:
-
Cellular pathway targeting panel
-
Immune panel for prediction of response to immunotherapy
Interested in learning more? Please visit DPLM for a requisition form.
bottom of page